Tracking the IMCR option chain helps you see every strike and expiry on Immunocore Holdings plc ADR in one view, so you can quickly identify the contracts that fit your thesis and your risk. Immunocore Holdings plc ADR's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of IMCR options activity at a glance. Use our scanner to monitor the IMCR option chain in real time and filter for the IMCR options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For IMCR stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the IMCR option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where IMCR stock options are being actively traded and where they are not.
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers.
In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Immunocore Holdings plc ADR's full chain across every expiry, highlights the most liquid strikes, and lets you screen IMCR options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of IMCR stock options — let the full option chain come to you, pre-filtered and ready to trade.
